EARLY PATIENT-REPORTED OUTCOMES AND CLINICAL OUTCOMES WITH ABT-494 IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS WHO ARE INADEQUATE RESPONDERS TO METHOTREXATE OR TUMOR NECROSIS FACTOR INHIBITORS: POST-HOC ANALYSIS OF PHASE 2 RANDOMIZED CONTROLLED TRIALS

被引：0
|
作者：
Strand, V. [1 ]
Tundia, N. [2 ]
Song, I. H. [2 ]
Meerwein, S. [2 ]
Lin, J. [2 ]
Chen, N. [2 ]
Friedman, A. [2 ]
机构：
[1] Stanford Univ, Palo Alto, CA 94304 USA
[2] AbbVie Inc, N Chicago, IL USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.1143
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0217
引用
收藏
页码：855 / 855
页数：1
相关论文
共 50 条
  • [21] Post Hoc Analysis of the Correlation Between Patient-Reported Outcomes and Clinical Response to Repository Corticotropin Injection for Persistently Active Rheumatoid Arthritis
    Fleischmann, Roy
    Hayes, Kyle
    Ahn, Sung-Woo
    Wan, George J.
    Panaccio, Mary P.
    Karlsson, Daniel
    Furst, Daniel E.
    RHEUMATOLOGY AND THERAPY, 2022, 9 (02) : 435 - 446
  • [22] PATIENT-REPORTED OUTCOMES FROM A PHASE 3 STUDY OF BARICITINIB VERSUS PLACEBO OR ADALIMUMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO BACKGROUND METHOTREXATE THERAPY
    Keystone, E.
    Taylor, P.
    Tanaka, Y.
    Gaich, C.
    DeLozier, A. M.
    Dudek, A.
    Zamora, J. Velasco
    Cobos, J. Covarrubias
    De Bono, S.
    Arora, V.
    Yang, L.
    Linetzky, B.
    Weinblatt, M. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 412 - 413
  • [23] The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies
    Clifton O. Bingham
    David Walker
    Peter Nash
    Susan J. Lee
    Lei Ye
    Hao Hu
    Javaria Mona Khalid
    Bernard Combe
    Arthritis Research & Therapy, 24
  • [24] The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies
    Bingham, Clifton O., III
    Walker, David
    Nash, Peter
    Lee, Susan J.
    Ye, Lei
    Hu, Hao
    Khalid, Javaria Mona
    Combe, Bernard
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [25] Maintenance of Patient-Reported Outcomes in Baricitinib-Treated Patients with Moderate-to-Severe Active Rheumatoid Arthritis: Post Hoc Analyses from Two Phase 3 Trials
    Sholter, Dalton
    Wu, Jianmin
    Jia, Bochao
    Zhang, Hong
    Griffing, Kirstin
    Birt, Julie
    Reis, Paulo Jorge Simoes
    Liu, Huaxiang
    Bingham, Clifton O., III
    RHEUMATOLOGY AND THERAPY, 2022, 9 (02) : 541 - 553
  • [26] Maintenance of Patient-Reported Outcomes in Baricitinib-Treated Patients with Moderate-to-Severe Active Rheumatoid Arthritis: Post Hoc Analyses from Two Phase 3 Trials
    Dalton Sholter
    Jianmin Wu
    Bochao Jia
    Hong Zhang
    Kirstin Griffing
    Julie Birt
    Paulo Jorge Simoes Reis
    Huaxiang Liu
    Clifton O. Bingham
    Rheumatology and Therapy, 2022, 9 : 541 - 553
  • [27] Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors: SPIRIT-P2 results to 52 weeks
    Kavanaugh, A.
    Marzo-Ortega, H.
    Vender, R.
    Wei, C. -C.
    Birt, J.
    Adams, D. H.
    Benichou, O.
    Lin, C. -Y.
    Nash, P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (04) : 566 - 574
  • [28] Effects of the oral Janus kinase inhibitor tofacitinib on patient-reported outcomes in patients with active rheumatoid arthritis: results of two Phase 2 randomised controlled trials
    Wallenstein, G. V.
    Kanik, K. S.
    Wilkinson, B.
    Cohen, S.
    Cutolo, M.
    Fleischmann, R.
    Genovese, M. C.
    Gomez Reino, J.
    Gruben, D.
    Kremer, J.
    Krishnaswami, S.
    Lee, E. B.
    Pascual-Ramos, V.
    Strand, V.
    Zwillich, S. H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (03) : 430 - 442
  • [29] Patient-Reported Outcomes in Patients with Lupus Nephritis: A Post Hoc Analysis of Control Arm Data from Two Completed Phase III Randomized Clinical Trials
    Tchakoute, Christophe T.
    Mao, Huiyan
    Wallenstein, Gene
    Terres, Jorge Ross
    Yoshida, Seitaro
    Lindsay, Lisa
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4008 - 4011
  • [30] RELATIONSHIP BETWEEN CLINICAL ASSESSMENTS AND PATIENT-REPORTED OUTCOMES: POST HOC ANALYSIS OF A RANDOMIZED, OPEN-LABEL STUDY OF ETANERCEPT IN LATIN AMERICAN PATIENTS WITH RHEUMATOID ARTHRITIS
    Guerra Bautista, Generoso
    Machado Xavier, Ricardo
    de la Vega, Maria
    Abraham Simon-Campos, J.
    Solano, Gaston
    Pedersen, Ronald D.
    Vlahos, Bonnie
    Borlenghi, Cecilia
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S72 - S72
12345